Status:
COMPLETED
Evaluation of NT PRO BNP Guided Therapy on Hospitalization Rate and Mortality in Patients With Chronic HF NYHA II-IY
Lead Sponsor:
Hillel Yaffe Medical Center
Conditions:
Chronic Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
To use continuous measurement of NT Pro BNP level as guide in therapy patients with CHF.
Detailed Description
Group of 100 patients with CHF, NYHA II-IY will be followed for 1 years in outpatient clinic of our hospital for hospitalization, death, 6 min walking protocol, number of decompensation as a primary e...
Eligibility Criteria
Inclusion
- Patient older 18 y.old with CHF NYHA II-IY.
Exclusion
- All conditions with life expectancy less than 2 years.
Key Trial Info
Start Date :
June 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT00469001
Start Date
June 1 2007
End Date
March 1 2010
Last Update
September 14 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hillel Yaffe Medical Center
Hadera, Israel, 38100